Craig-Hallum downgraded Avid Bioservices (CDMO) to Hold from Buy with a price target of $12.50, down from $16, after the company said it was getting acquired by GHO Capital and Ampersand Capital. The ...
Some results have been hidden because they may be inaccessible to you